2023-06-27 | Sale | Avalo Therapeutics, Inc. AVTX | 10 percent owner | | $0.52 | $486,888 | -85.36% | |
2023-06-26 | Sale | Avalo Therapeutics, Inc. AVTX | 10 percent owner | | $0.61 | $1.68M | -87.33% | |
2023-02-07 | Purchase | Avalo Therapeutics, Inc. AVTX | 10 percent owner | | $3.98 | $1.79M | -95.12% | |
2022-02-25 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $0.79 | $31,716 | -46.29% | |
2022-02-24 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $0.80 | $80,090 | -49.22% | |
2022-02-22 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $0.77 | $64,076 | -47.19% | |
2022-02-18 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $0.82 | $45,238 | -48.16% | |
2022-02-17 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $0.81 | $122,250 | -48.08% | |
2022-01-18 | Purchase | Avalo Therapeutics, Inc. AVTX | director | | $0.88 | $274,486 | -50.7% | |
2022-01-14 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $0.93 | $78,974 | -55.54% | |
2022-01-13 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $1.00 | $314,013 | -53.6% | |
2022-01-12 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $1.04 | $59,781 | -56.72% | |
2022-01-11 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $0.96 | $15,342 | -53.28% | |
2022-01-10 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $0.99 | $484,615 | -54.23% | |
2022-01-07 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $1.04 | $142,975 | -56.81% | |
2021-09-17 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $2.20 | $12M | -72.24% | |
2021-09-16 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $2.28 | $341,955 | -69.5% | |
2021-09-15 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $2.26 | $215,948 | -69.13% | |
2021-08-06 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $2.83 | $70,630 | -68.16% | |
2021-08-05 | Purchase | Avalo Therapeutics, Inc. AVTX | | | $2.77 | $69,295 | -68.12% | |